#biotechnology #biospace #lifesciences #pharmaceuticals #clinicalcatchup
Clinical trial, Pharmaceutical industry, Pharmacology, Informed consent, Immune system, Good clinical practice

Clinical Catch-Up: January 25-29

On Feb 2, 2021
@Biotechnology shared
Clinical Catch-Up: January 25-29 https://t.co/VDqf7tkoqx https://t.co/7P41kX2UYw
Open

It was a busy week for clinical trial news. Read on for more information.

www.biospace.com
On Feb 2, 2021
@Biotechnology shared
Clinical Catch-Up: January 25-29 https://t.co/VDqf7tkoqx https://t.co/7P41kX2UYw
Open

Clinical Catch-Up: January 25-29

Clinical Catch-Up: January 25-29

It was a busy week for clinical trial news. Read on for more information.

Clinical Catch-Up: June 22-26

Clinical Catch-Up: June 22-26

It was a busy week for clinical trial updates. Here’s a look.

Catching Up to Coronavirus: Top 60 Treatments in Development

Catching Up to Coronavirus: Top 60 Treatments in Development

GEN A-List shows 60 active COVID-19 drug development programs in North America, Europe, and China. More than two dozen of these treatments have emerged or been made public just in the two ...

Coronavirus Drug and Treatment Tracker

Coronavirus Drug and Treatment Tracker

An updated list of potential treatments for Covid-19.

Increasing number of biopharma drugs target COVID-19 as virus spreads

Increasing number of biopharma drugs target COVID-19 as virus spreads

In a flurry of catch-up following the coronavirus outbreak in China, a number of biopharma companies have announced development within the last few weeks to address the ever-spreading ...

Covid-19: what treatments are being investigated?

Covid-19: what treatments are being investigated?

With no current specific treatment for covid-19, the race is on to develop or repurpose drugs to help end the epidemic. The World Health Organization has now launched the SOLIDARITY trial ...

A Year to Remember: The Biggest European Biotech News in 2020

A Year to Remember: The Biggest European Biotech News in 2020

The Covid-19 pandemic caused huge disruption for European biotech in 2020, but the industry pulled through. Let’s look back at some of the top moments in the last 12 months.  After the many ...

As Rhythm Pharmaceuticals preps for first approval, CEO hits the exit

As Rhythm Pharmaceuticals preps for first approval, CEO hits the exit

Fierce 15 winner Rhythm Pharmaceuticals is on the cusp of gaining its first approval in 2020, but it will be ushering in this potential milestone without its chief.

Vir Biotechnology and GSK announce global expansion to Phase 3 of COMET-ICE study evaluating VIR-7831 for the treatment of COVID-19

Vir Biotechnology and GSK announce global expansion to Phase 3 of COMET-ICE study evaluating VIR-7831 for the treatment of COVID-19

Independent Data Monitoring Committee recommended on September 30, 2020 that the study continue into Phase 3 based on a positive evaluation of safety and tolerability data from the Phase 2 ...

Vir Biotechnology and GSK announce start of NIH-sponsored ACTIV-3 trial evaluating VIR-7831 in hospitalised adults with COVID-19

Vir Biotechnology and GSK announce start of NIH-sponsored ACTIV-3 trial evaluating VIR-7831 in hospitalised adults with COVID-19

Global Phase 3 trial will investigate the safety and efficacy of VIR-7831 in hospitalised adults with COVID-19

Merck & Co adds COVID-19 drug to pipeline with OncoImmune buy

Merck & Co adds COVID-19 drug to pipeline with OncoImmune buy

Merck & Co is to buy US biotech OncoImmune for at least $425m, adding a potential new therapy for COVID-19 to its pipeline.

The drugs and treatments that could stop Covid-19

The drugs and treatments that could stop Covid-19

More than 70 clinical trials have registered with the Food and Drug Administration.

Ideas for an FDA Reboot

Ideas for an FDA Reboot

The FDA needs to get healthy, and fast. Its credibility as the world’s No. 1 science-based regulator of food and drugs has been tarnished. From the start, it had to play catch-up on RT-PCR ...

Finally, some good news about Ebola: Two new treatments dramatically lower the death rate in a trial

Finally, some good news about Ebola: Two new treatments dramatically lower the death rate in a trial

The therapies, both monoclonal antibody preparations, will now be used to treat all patients